TAXONOMY:

Quality Measures

Mirixa has developed customized clinical rules and algorithms to address quality measures such as Star Ratings, HEDIS, and other evidence-based standards of care.

The MirixaPro℠ platform focuses on medication-related quality measures through specific alerts, disease modules, and/or specific preventive care modules.

 

Star Ratings

Medicare Part D plans (PDP) and Medicare Advantage plans with prescription benefit (MA-PD) are rated on multiple performance measures. Mirixa MTM Programs and Star Ratings solutions address the drug safety measures that can influence and improve about 40% of total Part D summary rating. Our solutions address:

  • High Risk Medications
  • Medication Adherence for Diabetes Medications
  • Medication Adherence for Hypertension (RAS antagonists)
  • Medication Adherence for Cholesterol (Statins)

The "MTM Program Completion Rate for CMR" quality measure is also addressed by our MTM Programs.

 

HEDIS Improvement

Mirixa's Targeted Quality Interventions solutions support Mirixa or payer-targeted interventions, which influence many HEDIS quality measures, including but not limited to, the following:

  • Medication Management for People with Asthma
  • Asthma Medication Ratio
  • Statin Therapy and Diabetes
  • Antidepressant Management
  • Anti-psychotic Medication in Schizophrenia